---
title: Dose-Response Relationship in Patients with Liver Metastases from Neuroendocrine
  Neoplasms Undergoing Radioembolization with <sup>90</sup>Y Glass Microspheres
date: '2024-06-21'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38906556/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240622182948&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'The benefit of multicompartment dosimetry in the radioembolization of
  neuroendocrine neoplasms is not firmly established. We retrospectively assessed
  its potential with patient outcome. Methods: Forty-three patients were eligible.
  The association of mean absorbed dose (MAD) for tumors and treatment response was
  tested per lesion with a receiver operating characteristic curve analysis, and the
  association of MAD with progression-free survival (PFS) and overall survival was
  tested per ...'
disable_comments: true
---
The benefit of multicompartment dosimetry in the radioembolization of neuroendocrine neoplasms is not firmly established. We retrospectively assessed its potential with patient outcome. Methods: Forty-three patients were eligible. The association of mean absorbed dose (MAD) for tumors and treatment response was tested per lesion with a receiver operating characteristic curve analysis, and the association of MAD with progression-free survival (PFS) and overall survival was tested per ...